News & Media

Optogenetics is a rapidly evolving research technology, with an increasing number of highly-cited publications, licensed patents and now two clinical trials employing the tool in some way. With a growing Australian optogenetics research community, Optogenetics Australia was established to support the application and development of optogenetics and to translate their findings into benefits for the academic research community and beyond. As such, ARMI is proud to have supported Optogenetics Australia’s first major milestone by helping host the 1st Hands-On Workshop earlier this month.

The student body forms such an integral part of a research institute. Not only are they key participants in the work involved in scientific discovery, but also significant contributors to the overall fun of the laboratory; injecting youthful enthusiasm into the atmosphere, imparting invigorating energy in the lab, and sharing fresh ideas with the research cohort. With this, it is exciting to see a record number of Honours and PhD students starting at ARMI in 2020, in addition to our group of Master and UROP students.

ARMI group leader Alberto Roselló-Díez is a young researcher on the rise. With already a decorated 2019 in tow, Alberto has kicked off 2020 with yet another award - the 2020 ASBMR [American Society for Bone and Mineral Research] John Haddad Young Investigator Award.

Over 700,000 Australians have a brain or spinal cord injury. The majority of these Australians are under 40, with two out of every three brain injuries happening before the age of 25. Many of these patients will need lifelong care, making it a financial burden not only on the patient, but also the healthcare system. Beyond the monetary, brain and spinal cord injuries can have devastating effects on a patient’s ability to function, on a patient’s mental wellbeing and on a patient’s relationships.

The year 2022 will be a landmark year for the Monash University Clayton campus as it is the year the Victorian Heart Hospital, Australia's first hospital to be dedicated to cardiac care, is due to be completed.

The November 2019 of the ARMI newsletter, Regenerate, is now available to view in the 'Resources' section. Here are some of the highlights for ARMI in November:

• Seeing More Clearly Now with New Research
• Cracking the Hox Code
• Hopes high for futuristic tissue healing method
• Cells study helping to crack the code to Alzheimer’s disease
• Unravelling congenital muscular dystrophy
• Martino group's Women in STEMM excelling
• ARMI at the Monash FMNHS ECR Symposium
• Welcome to our latest recruits

Discover what other highlights have emerged and keep up to date with ARMI in the latest edition of Regenerate.

An Australia-led team of scientists has developed technology to speed up the mending of damaged bone, skin and, potentially, other tissue.

A study led by researchers at Monash University has opened up new hope for diagnosing and treating Alzheimer’s disease. The study, led by Monash University’s Professor Jose Polo, from the Monash Biomedicine Discovery Institute and the Australian Regenerative Medicine Institute, focused on how individual cell types in the brain contribute to Alzheimer’s disease.

The human body navigates movement with astonishing success, displaying locomotor actions that are fluid and coordinated. This ability is the mystery that the McGlinn group is attempting to unravel. Now, they are one step closer with the recent publication of their paper, "A Hox code defines spinocerebellar neuron subtype regionalisation" in Cell Reports.

2018 has been another excellent year for the Australian Regenerative Medicine Institute (ARMI), with growth in the quality of our research and in the global and industry collaborations that are so important for 21st century medical research. As you will read throughout this report, 2018 was a year of numerous success stories in research, industry and international collaboration.